2013 HCPCS G9090
Evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-2, n0, m0 (prior to neo-adjuvant therapy, if any) with no

  • This is the 2013 version of HCPCS G9090 - please refer to the 2016 HCPCS code set for the latest version.

  G9089    G9091